RWE62 - RWD Shows Treatment Effectiveness with 30,000 Patients

RWD Shows Treatment Effectiveness with 30,000 Patients

Swedish researchers investigated whether there were any clinically meaningful differences between anti-psychotic medications’ effectiveness in treating schizophrenia A RWD database was used to carry out the nationwide study RWE allowed the study to find the treatments most likely to prevent relapses Click here to see the source article    About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in […]

Read More
RWE61 - Oncology Electronic Prescribing Records Chart Note study

Oncology RWE – Electronic Prescribing Records Chart Note Study

RWE Oncology Electronic Prescribing Records provide a unique opportunity to conduct large scale chart note reviews within all NHS hospitals in the UK SVMPharma Oncology Electronic Prescribing Records Chart notes have studied more than 6,000 patients in multiple tumour sites (prostate cancer, renal cell carcinoma, ovarian cancer, and lung cancer) Oncology Electronic Prescribing Records provide […]

Read More
RWE60 - RWE defines

Real World Evidence can define treatment information

RWE provides many useful insights, and is currently being used primarily for RCT evidence supplementation ” …it’s clear that real-world data will play an increasingly important role in how drugs are assessed in the future.”“Industry, academia and the public sector will all have to work together to make this a real priority.” – Dr Linda […]

Read More
RWE59 - Do RWE results match those from RCTs

Do RWE results match those from RCTs?

A pilot study led by Friends of Cancer Research (Friends) investigated how real world evidence (RWE) compares to the results from randomised clinical trials (RCTs) (for advanced non-small cell lung cancer). The study showed consistency between RWE and RCTs, emphasising their potential for supporting clinical decision-making “RWE is an important tool for continued learning about treatment outcomes […]

Read More
RWE58-Real World Evidence shows impact of HPV vaccines on cervical cancer

Real World Evidence shows impact of HPV vaccines on cervical cancer

A systematic review and meta-analysis has shown strong evidence of the effectiveness of the HPV vaccine “Our results can be used by clinicians to illustrate the real-world impact of HPV vaccination outside the very controlled settings of randomized trials.” – Marc Brisson, PhD (Université Laval, Quebec, Canada) “…it was interesting that the promising HPV vaccine efficacy […]

Read More
RWE57 - FDA’s INFORMED science and technology incubator, to bring real world data to the development of breast cancer treatment

FDA’s INFORMED science and technology incubator, to bring real world data to the development of breast cancer treatment

In 332,630 new cases of breast cancer, only 3% – 5% of patients participated in traditional clinical studies. RWE: “expected to allow for deeper insights and greater understanding of the variance of patient treatment outcomes” An initial two year contract focused on breast cancer, but there’s potential to explore other cancer epidemiology Click here to see the source article    About SVMPharma […]

Read More
RWE56 - Why sample size matters

Why sample size matters

1000 patient record study with Cancer Electronic Prescribing Records (EPRs), the data source for SACT. RWE to be used in improving patient care. Click here to see the source article    About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online […]

Read More
RWE55 - FDA encourages RWE in oncology

FDA encourages RWE in oncology

RWE can provide deep and accurate real-world clinical evidence, providing useful data for the increasingly stratified molecular subtypes of cancer “When we enable oncologists to see patient data clearly, we can make sure that everyone touched by cancer finds the right path to the right care.” Click here to see the source article    About SVMPharma SVMPharma is an […]

Read More
RWE54 - RWE highlights treatment gaps in Major Depressive Disorder patients

RWE highlights treatment gaps in Major Depressive Disorder patients

“Data Presented at the American Psychiatric Association 2019 Meeting Suggest a Low Rate of Psychiatric Care Received by Adult Patients with MDD Before Suicide Ideation or Attempt Diagnosis” “Additional Data Show Patients Have a High Risk of Hospital Readmission or Subsequent Emergency Department Visit after Suicide Ideation or Attempt” Click here to see the source article  About SVMPharma SVMPharma […]

Read More
RWE53

Leveraging RWD to improve regulatory decisions

How real world evidence was used to support approval of Ibrance for male breast cancer “Leveraging RWD to improve regulatory decisions is a key strategic priority for the FDA. This data may be derived from a variety of sources, such as electronic health records, medical claims, product and disease registries, laboratory test results and even […]

Read More